Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,330
-10 (-0.07%)
Last updated: Apr 17, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 286.57 billion as of April 17, 2025. Its market cap has decreased by -11.17% in one year.
Market Cap
286.57B
Enterprise Value
436.99B
Revenue
598.16B
Ranking
n/a
PE Ratio
18.97
Stock Price
13,330.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 286.57B, an increase of 1,486.75%. That is a compound annual growth rate of 12.13%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.66T |
Celltrion | 33.89T |
ALTEOGEN | 20.94T |
Yuhan | 8,633.29B |
SK Biopharmaceuticals | 8,207.23B |
HLB Co., Ltd. | 7,214.15B |
Peptron | 4,195.85B |
LigaChem Biosciences | 3,958.37B |